Medications

Not enough new antibiotics in the pipeline, WHO review concludes

A review from WHO on the number of new antibiotics currently in the pipeline shows that just 12 new antibiotics have entered the market in the five years from 2017-21. And there are far too few (just 27) under development ...

Diseases, Conditions, Syndromes

How to overcome challenges in forecasting antimicrobial resistance

A group of researchers led by Sen Pei at Columbia University's Mailman School of Public Health discussed the utility of real-time forecasting models for antimicrobial-resistant organisms. The article appears in the journal ...

page 38 from 40